Solid Biosciences SLDB
NASDAQ SLDB
$10.25 -0.17 (-1.63%)
At close: Sep 4, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Times Interest Earned (2023 - 2025)

Solid Biosciences (SLDB) posted Times Interest Earned of -$10.55 for Q1 2026, up 6.36% sequentially from -$11.27 in Q4 2025, and up 96.31% YoY from -$5.38 in Q1 2025.

Analysis

Solid Biosciences (SLDB) Times Interest Earned (2023 - 2025) Analysis & Trends

Solid Biosciences has reported Times Interest Earned for 10 years, with the latest figure at -$10.55 in Q1 2026.

  • Quarterly Times Interest Earned rose 96.31% year-over-year to -$10.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.17 (up 96.46% YoY) and the FY2025 annual result came in at -$0.94, up 5.2% from the prior year.
  • Times Interest Earned rose to -$10.55 in Q1 2026 per SLDB's latest filing, from -$11.27 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$0.21 in Q4 2022 and troughed at -$497.49 in Q1 2022.
  • A 5-year average of -$176.93 and a median of -$208.05 in 2022 frame the typical range for Times Interest Earned.
  • The sharpest annual moves came in 2023 and 2026: Times Interest Earned sank 2431.42% in 2023, then jumped 96.31% in 2026.
  • Over 5 years, Times Interest Earned stood at -$0.21 in 2022, then tumbled by 2431.42% to -$5.35 in 2023, then plunged by 86.49% to -$9.98 in 2024, then declined by 12.95% to -$11.27 in 2025, then climbed by 6.36% to -$10.55 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods registered -$10.55, -$11.27, and -$29.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Solid Biosciences 1.48 Bn 1.48 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9,880.60
Sep 30, 2025 143.03
Jun 30, 2025 -694.88
Mar 31, 2025 -589.00
Dec 31, 2024 -531.95
Sep 30, 2024 -429.05
Jun 30, 2024 -315.77
Mar 31, 2024 -282.76
Dec 31, 2023 -220.45
Sep 30, 2023 -218.06
Jun 30, 2023 -241.83
Mar 31, 2023 -264.71